Table 1. The results of the OSPL-502 concentration determination in plasma samples taken at appropriate time intervals, with oral (i/p) and intravenous administration (i/v) of the dosage form (mg/kg) in terms of the substance.
Time, h |
Concentration of OSPL-502, ng/ml |
|
10, i/p |
2, i/v |
|
0,25 |
1992,43 ± 607.54 |
2740,22 ± 694,15 |
0,5 |
1229,68 ± 18,78 |
185,65 ± 40,29 |
0,75 |
1388,14 ± 74,27 |
161,16 ± 35,94 |
1 |
822,21 ± 53,82 |
132,43 ± 20,33 |
1,5 |
2451,71 ± 256,32 |
103,24 ± 26,12 |
2 |
1741,54 ± 247,44 |
33,34 ± 17,85 |
4 |
726, 22 ± 117,72 |
7,24 ± 3,14 |
8 |
676,77 ± 145,23 |
4,22 ± 2,31 |
16 |
377,89 ± 7,87 |
--- |
24 |
312,24 ± 25,34 |
--- |